Prot No. GS-US-256-0124: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Response Guided Therapy using Combinations of Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) with Peginterferon Alfa 2a and Ribavirin in Treatment Exp

Project: Research project

Project Details

StatusFinished
Effective start/end date7/26/117/26/14

Funding

  • PRA Health Sciences (Prot No. GS-US-256-0124)
  • Gilead Sciences, Inc. (Prot No. GS-US-256-0124)